Deborah A. Katz

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines

Gerhard Zugmaier, Bruce W. Ennis, Bernd Deschauer et al. · Journal of Cellular Physiology · 1989 · 132 citations

The Effects of a Constitutive Expression of Transforming Growth Factor-α on the Growth of MCF-7 Human Breast Cancer Cells<i>in Vitro</i>and<i>in Vivo</i>

Robert Clarke, Nils Brünner, Deborah A. Katz et al. · Molecular Endocrinology · 1989 · 127 citations

Breast Oncology, Cell Proliferation, Cancer Biology +18

Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes.

Deborah A. Katz, Mitchell A. Lazar · Journal of Biological Chemistry · 1993 · 119 citations · Full text

Tr Alpha/vp16, Genetics, Molecular Biology +19

Loss of Orphan Receptor Germ Cell Nuclear Factor Function Results in Ectopic Development of the Tail Bud and a Novel Posterior Truncation

Arthur Chung, Deborah A. Katz, Fred A. Pereira et al. · Molecular and Cellular Biology · 2001 · 108 citations · Full text